SK5712003A3 - Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same - Google Patents
Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same Download PDFInfo
- Publication number
- SK5712003A3 SK5712003A3 SK571-2003A SK5712003A SK5712003A3 SK 5712003 A3 SK5712003 A3 SK 5712003A3 SK 5712003 A SK5712003 A SK 5712003A SK 5712003 A3 SK5712003 A3 SK 5712003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- amino
- formula
- dihydro
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0013125A FR2815346B1 (fr) | 2000-10-13 | 2000-10-13 | Nouveaux composes aminotriazolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
PCT/FR2001/003133 WO2002030923A1 (fr) | 2000-10-13 | 2001-10-11 | Nouveaux composes aminotriazolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
SK5712003A3 true SK5712003A3 (en) | 2003-11-04 |
Family
ID=8855314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK571-2003A SK5712003A3 (en) | 2000-10-13 | 2001-10-11 | Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040029875A1 (no) |
EP (1) | EP1324998A1 (no) |
JP (1) | JP2004515475A (no) |
KR (1) | KR20030036929A (no) |
CN (1) | CN1468233A (no) |
AR (1) | AR031726A1 (no) |
AU (1) | AU2002210632A1 (no) |
BR (1) | BR0114632A (no) |
CA (1) | CA2424802A1 (no) |
CZ (1) | CZ20031290A3 (no) |
EA (1) | EA200300458A1 (no) |
FR (1) | FR2815346B1 (no) |
HU (1) | HUP0302408A2 (no) |
MX (1) | MXPA03002956A (no) |
NO (1) | NO20031643D0 (no) |
PL (1) | PL360090A1 (no) |
SK (1) | SK5712003A3 (no) |
WO (1) | WO2002030923A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101674801A (zh) * | 2007-01-31 | 2010-03-17 | 西巴控股公司 | 阳离子染料 |
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
KR101897881B1 (ko) | 2008-01-04 | 2018-09-12 | 인텔리카인, 엘엘씨 | 특정 화학 물질, 조성물 및 방법 |
KR100971811B1 (ko) * | 2008-03-27 | 2010-07-22 | 엘에스전선 주식회사 | 커넥터가 구비된 광복합 전력케이블 접속함 |
US8809349B2 (en) | 2011-01-10 | 2014-08-19 | Infinity Pharmaceuticals, Inc. | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
US10046974B2 (en) | 2013-02-05 | 2018-08-14 | Basf Se | Process for preparing a boron containing zeolitic material having MWW framework structure |
WO2015160975A2 (en) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Combination therapies |
CA3028718A1 (en) | 2016-06-24 | 2017-12-28 | Infinity Pharmaceuticals, Inc. | Combination therapies |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2435521C3 (de) * | 1974-07-24 | 1982-01-21 | L. & C. Steinmüller GmbH, 5270 Gummersbach | Selbsttragendes Beton-Stahl-Verbundelement zur Auskleidung von Behältern |
PT76280A (en) * | 1982-02-24 | 1983-03-01 | Glaxo Group Ltd | Process for preparing heterocyclic derivatives |
GB2236339B (en) * | 1989-09-07 | 1994-06-01 | Kajima Corp | Trusses and precast concrete slabs reinforced thereby |
DE4326465A1 (de) * | 1993-01-20 | 1995-02-09 | Thomae Gmbh Dr K | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
AU7738198A (en) * | 1996-12-15 | 1998-07-15 | Banyu Pharmaceutical Co., Ltd. | Aminopyrazole derivatives |
PE20000127A1 (es) * | 1997-12-22 | 2000-03-14 | Novartis Ag | Derivado de bencenosulfonamida |
-
2000
- 2000-10-13 FR FR0013125A patent/FR2815346B1/fr not_active Expired - Fee Related
-
2001
- 2001-10-11 CA CA002424802A patent/CA2424802A1/fr not_active Abandoned
- 2001-10-11 AU AU2002210632A patent/AU2002210632A1/en not_active Abandoned
- 2001-10-11 HU HU0302408A patent/HUP0302408A2/hu unknown
- 2001-10-11 JP JP2002534309A patent/JP2004515475A/ja active Pending
- 2001-10-11 BR BR0114632-7A patent/BR0114632A/pt not_active IP Right Cessation
- 2001-10-11 US US10/399,098 patent/US20040029875A1/en not_active Abandoned
- 2001-10-11 EA EA200300458A patent/EA200300458A1/ru unknown
- 2001-10-11 CZ CZ20031290A patent/CZ20031290A3/cs unknown
- 2001-10-11 WO PCT/FR2001/003133 patent/WO2002030923A1/fr not_active Application Discontinuation
- 2001-10-11 EP EP01978526A patent/EP1324998A1/fr not_active Withdrawn
- 2001-10-11 MX MXPA03002956A patent/MXPA03002956A/es not_active Application Discontinuation
- 2001-10-11 CN CNA018170587A patent/CN1468233A/zh active Pending
- 2001-10-11 PL PL01360090A patent/PL360090A1/xx not_active Application Discontinuation
- 2001-10-11 SK SK571-2003A patent/SK5712003A3/sk unknown
- 2001-10-11 KR KR10-2003-7005208A patent/KR20030036929A/ko not_active Application Discontinuation
- 2001-10-12 AR ARP010104790A patent/AR031726A1/es not_active Application Discontinuation
-
2003
- 2003-04-10 NO NO20031643A patent/NO20031643D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002030923A1 (fr) | 2002-04-18 |
CZ20031290A3 (cs) | 2003-08-13 |
CA2424802A1 (fr) | 2002-04-18 |
US20040029875A1 (en) | 2004-02-12 |
FR2815346A1 (fr) | 2002-04-19 |
FR2815346B1 (fr) | 2004-02-20 |
BR0114632A (pt) | 2004-02-17 |
CN1468233A (zh) | 2004-01-14 |
JP2004515475A (ja) | 2004-05-27 |
MXPA03002956A (es) | 2004-12-13 |
HUP0302408A2 (hu) | 2003-12-29 |
NO20031643L (no) | 2003-04-10 |
AU2002210632A1 (en) | 2002-04-22 |
AR031726A1 (es) | 2003-10-01 |
KR20030036929A (ko) | 2003-05-09 |
NO20031643D0 (no) | 2003-04-10 |
EP1324998A1 (fr) | 2003-07-09 |
EA200300458A1 (ru) | 2003-08-28 |
PL360090A1 (en) | 2004-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1044970B1 (fr) | Nouveaux composés aminotriazoles, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
EP1183245B1 (en) | Selective npy (y5) antagonists | |
EP1432700B1 (en) | Spiro-hydantoin compounds useful as anti-inflammatory agents | |
RU2146253C1 (ru) | Производные 4-фениламинотиазола, способы их получения и фармацевтическая композиция | |
EP1720544A1 (fr) | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
JPH08505862A (ja) | アミノ酸誘導体、これらの化合物を含む医薬組成物及びそれらの調製方法 | |
EP1790641A1 (en) | Triazole derivative or salt thereof | |
JP2004523583A5 (no) | ||
JPH072851A (ja) | 5員複素環化合物、それらの調製方法及びこれらの化合物を含む医薬組成物 | |
BG60937B2 (bg) | Тетрахидронафталени и съдържащи ги лекарствени средства | |
US20040162278A1 (en) | Triazole compounds useful in therapy | |
SK5712003A3 (en) | Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same | |
US7449462B2 (en) | Triazole derivatives which inhibit vasopressin antagonistic activity | |
EP1242389B1 (fr) | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant | |
Wang et al. | Synthesis of 2-thiohydantoins as somatostatin subtype 4 receptor ligands | |
CA2557642A1 (en) | Ion channel modulators | |
WO2022200162A1 (en) | Novel potassium channel inhibitors | |
AU2776500A (en) | New aminotriazole compounds, a process for their preparation and pharmaceutical compositions containing them |